SCHEMBL6719484

SCHEMBL6719484

COCCCN1CCCc2c[c]ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REN P00797 4/20 0.46
CYP3A4 P08684 1/20 0.44
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
HRH3 Q9Y5N1 4/20 0.40
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CHRM2 P08172 3/20 0.36
CHRM4 P08173 3/20 0.36
CHRM1 P11229 3/20 0.36
CHRM3 P20309 3/20 0.36
MAPT P10636 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
DRD2 P14416 2/20 0.34
DRD3 P35462 2/20 0.34
NPC1 O15118 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27192643 0.92 MEN1 (0.43) RENCYP3A4MEN1ALDH1A1KMT2A
SCHEMBL6714618 0.90 REN (0.47) RENCYP3A4MEN1ALDH1A1KMT2A
SCHEMBL28477103 0.86 MEN1 (0.50) RENCYP3A4MEN1ALDH1A1KMT2A
SCHEMBL2090062 0.82 MEN1 (0.60) MEN1ALDH1A1KMT2AHRH3CHRM2
SCHEMBL8568452 0.81 ALDH1A1 (0.63) RENCYP3A4MEN1ALDH1A1KMT2A
SCHEMBL9829903 0.79 ALDH1A1 (0.44) MEN1ALDH1A1KMT2AHRH3CHRM2
SCHEMBL6713240 0.79 CHRM2 (0.39) MEN1ALDH1A1KMT2ACHRM2CHRM4
SCHEMBL6719956 0.79 REN (0.46) RENCYP3A4CHRM2CHRM4CHRM1
SCHEMBL10996183 0.76 ALDH1A1 (0.60) RENCYP3A4MEN1ALDH1A1KMT2A
SCHEMBL6234280 0.76 ALDH1A1 (0.44) MEN1ALDH1A1KMT2ACHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040214832-A1 Piperazine derivative renin inhibitors WARNER-LAMBERT COMPANY LLC 2004-10-28 US claimed
US-20040204455-A1 Piperidine derivative rennin inhibitors WARNER-LAMBERT COMPANY LLC 2004-10-14 US claimed
US-20040214832-A1 Piperazine derivative renin inhibitors WARNER-LAMBERT COMPANY LLC 2004-10-28 US disclosed
US-20040204455-A1 Piperidine derivative rennin inhibitors WARNER-LAMBERT COMPANY LLC 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204455-A1 Piperidine derivative rennin inhibitors REN, ACE, HPN REN 1/4885CYP3A4 2949/4885MEN1 4236/4885
US-20040214832-A1 Piperazine derivative renin inhibitors REN, ACE, AGTR2 REN 1/4885CYP3A4 1308/4885MEN1 4599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.